To develop cell culture and small animal models of Nipah virus replication and pathogenesis in a biosafety level (BSL) 4 lab.

To assist the Ministry of Public Health (MOPH) in establishing a Field Epidemiology Training Program (FETP) in Qatar focused on building its public health workforce capacity.

To investigate other novel interventions, such as monoclonal antibodies (MAbs) against malaria. An intervention that could prevent malaria in children for a full 12 months in settings of perennial malaria transmission, such as Kenya, holds potential to reduce malaria morbidity and mortality substantially in this population at risk for severe malaria and death.

To expand CDC’s strategic engagement in learning and evaluation of best practices for water, sanitation and hygiene (WASH) in health care facilities through implementation of targeted action research pilots in Uganda.

To evaluate a novel intravaginal ring to prevent HIV infection combined with a contraceptive to prevent unintended pregnancy. MATRIX stands for Microbicide Research and Development to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence.

To ensure impact and effectiveness of rotavirus vaccines and sustain vaccine use by policy makers, physicians and parents to increase the speed of adoption of vaccine by other countries in Africa and around the world.

To evaluate a model of oral HIV pre-exposure prophylaxis (PrEP) implementation for youth that includes home PrEP (with fewer in-person clinic visits and a telemedicine approach). The objective is to evaluate the safety, acceptability of and adherence to home-based daily oral PrEP among young men who have sex with men and transgender women.

To assess the impact of the Pneumococcal conjugate vaccine catch up campaign among internally displaced populations in the northern Sahel region of Burkina Faso. This effort will implement and evaluate the impact of changing the pneumococcal conjugate vaccine schedule.

To pilot the training of scientists at the first PARMA (PMI-supported Antimalarial Resistance Monitoring in Africa) site in Africa in Senegal.

To support the characterization of non-rotavirus viral diarrheal pathogens to inform the body of work that contributes to optimize the efficacy of rotavirus vaccines.